MoleculeGo против BioViewer Использование & Stats

MoleculeGo is a location based app that gamifies the process of learning about molecular biology. In this game, the player collects amino acids, ATP, and DNA sequences, the molecular building blocks used to synthesize proteins. By capturing DNA sequences, the player discovers genes that encode for proteins. These genes provide the user with the necessary "recipe" to synthesize proteins in their own lab, using amino acids and ATP. These proteins can then be combined to construct even larger protein complexes. As the player progresses in the game, new molecules become available and information will become available about each molecule's basic function and how its structure is associated with its molecular role. Players can visit hotspots (schools, parks, hospitals, universities, etc.) to accelerate the discovery of new molecules. While molecules are discovered, players can learn how they are involved in disease, biomedical applications, research, and their function in the cell.
  • Apple App Store
  • Бесплатный
  • Образование

Рейтинг магазина

- -

A .pdb protein visualizer for iOS, iPadOS and macOS. View the 3D representation of any molecular structure from a .pdb file, using our custom Metal-based rendering engine based to allow for a smooth experience even in the biggest proteins.  - Full drag and drop support for .pdb and .xyz files. - Photo Mode with publication-quality exports. - Support for multi-model PDBs. - Support for high refresh rate ProMotion displays.
  • Apple App Store
  • Бесплатный
  • Образование

Рейтинг магазина

- -

MoleculeGo vs. BioViewer ranking comparison

Compare MoleculeGo ranking trend in the past 28 days vs. BioViewer

Rank

Нет данных

Рейтинг MoleculeGo против BioViewer в сравнении по странам

Сравните динамику рейтинга MoleculeGo за последние 28 дней с динамикой рейтинга BioViewer.

Нет данных для отображения

Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией

Начать
MoleculeGo VS.
BioViewer

декабрь 17, 2024